Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Avorn

Showing results (221-230 of 308) with videos related to

Pageof 31
Sort By:
Arthritis Research & Therapy|August 23, 2008
Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary studyGladys Ting, Sebastian Schneeweiss, Richard Scranton, et al.
Arthritis and Rheumatism|August 1, 2008
Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groupsDaniel H Solomon, Robert J Glynn, Kenneth J Rothman, et al.
Medical Care|April 30, 2003
Trends in knee magnetic resonance imagingDaniel H Solomon, Jeffrey N Katz, John A Carrino, et al.
JAMA Internal Medicine|January 2, 2013
Variations in pill appearance of antiepileptic drugs and the risk of nonadherenceAaron S Kesselheim, Alexander S Misono, William H Shrank, et al.
Archives of Internal Medicine|November 17, 2005
Compliance with osteoporosis medicationsDaniel H Solomon, Jerry Avorn, Jeffrey N Katz, et al.
Journal of Clinical Psychopharmacology|September 15, 2005
Pharmacogenetic testing in the clinical management of schizophrenia: a decision-analytic modelRoy H Perlis, David A Ganz, Jerry Avorn, et al.
Plos Medicine|October 15, 2014
Association of medical students' reports of interactions with the pharmaceutical and medical device industries and medical school policies and characteristics: a cross-sectional studyJames S Yeh, Kirsten E Austad, Jessica M Franklin, et al.
Archives of General Psychiatry|December 10, 2002
Dopamine antagonists and the development of breast cancerPhilip S Wang, Alexander M Walker, Ming T Tsuang, et al.
Pharmacoepidemiology and Drug Safety|April 28, 2017
Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medicationsAaron S Kesselheim, Macarius Donneyong, Gerald J Dal Pan, et al.
Arthritis and Rheumatism|August 1, 2007
Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimalGabriela Schmajuk, Sebastian Schneeweiss, Jeffrey N Katz, et al.
Pageof 31

Showing results (221-230 of 308) with videos related to

Sort By:
Pageof 31
Arthritis Research & Therapy|August 23, 2008
Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary studyGladys Ting, Sebastian Schneeweiss, Richard Scranton, et al.
Arthritis and Rheumatism|August 1, 2008
Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groupsDaniel H Solomon, Robert J Glynn, Kenneth J Rothman, et al.
Medical Care|April 30, 2003
Trends in knee magnetic resonance imagingDaniel H Solomon, Jeffrey N Katz, John A Carrino, et al.
JAMA Internal Medicine|January 2, 2013
Variations in pill appearance of antiepileptic drugs and the risk of nonadherenceAaron S Kesselheim, Alexander S Misono, William H Shrank, et al.
Archives of Internal Medicine|November 17, 2005
Compliance with osteoporosis medicationsDaniel H Solomon, Jerry Avorn, Jeffrey N Katz, et al.
Journal of Clinical Psychopharmacology|September 15, 2005
Pharmacogenetic testing in the clinical management of schizophrenia: a decision-analytic modelRoy H Perlis, David A Ganz, Jerry Avorn, et al.
Plos Medicine|October 15, 2014
Association of medical students' reports of interactions with the pharmaceutical and medical device industries and medical school policies and characteristics: a cross-sectional studyJames S Yeh, Kirsten E Austad, Jessica M Franklin, et al.
Archives of General Psychiatry|December 10, 2002
Dopamine antagonists and the development of breast cancerPhilip S Wang, Alexander M Walker, Ming T Tsuang, et al.
Pharmacoepidemiology and Drug Safety|April 28, 2017
Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medicationsAaron S Kesselheim, Macarius Donneyong, Gerald J Dal Pan, et al.
Arthritis and Rheumatism|August 1, 2007
Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimalGabriela Schmajuk, Sebastian Schneeweiss, Jeffrey N Katz, et al.
Pageof 31